{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:42:41Z","timestamp":1790754161343,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T00:00:00Z","timestamp":1687910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Despite considerable advances, there is a need to improve the\u00a0outcomes of newborn infants, especially related to prematurity, encephalopathy and other conditions. In principle, cell therapies have\u00a0the potential to protect, repair, or sometimes regenerate vital tissues; and improve or sustain organ function. In this review, we present highlights from the First Neonatal Cell Therapies Symposium (2022). Cells tested in preclinical and clinical studies include mesenchymal stromal cells from various sources, umbilical cord blood and cord tissue derived cells, and placental tissue and membrane derived cells. Overall, most preclinical studies suggest potential for benefit, but many of the cells tested were not adequately defined, and the optimal cell type, timing, frequency, cell dose or the most effective protocols for the targeted conditions is not known. There is as yet no clinical evidence for benefit, but several early phase clinical trials are now assessing safety in newborn babies. We discuss parental perspectives on their involvement in these trials, and lessons learnt from previous translational work of promising neonatal therapies. Finally, we make a call to the many research groups around the world working in this exciting yet complex field, to work together to make substantial and timely progress to address the knowledge gaps\u00a0and move the field forward.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Impact<\/jats:title>\n                <jats:p><jats:list list-type=\"bullet\">\n                  <jats:list-item>\n                    <jats:p>Survival of preterm and sick newborn infants is improving, but they continue to be at high risk of many systemic and organ-specific complications.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Cell therapies show promising results in preclinical models of various neonatal conditions and early phase clinical trials have been completed or underway.<\/jats:p>\n                  <\/jats:list-item>\n                  <jats:list-item>\n                    <jats:p>Progress on the potential utility of cell therapies for neonatal conditions, parental perspectives and translational aspects are discussed in this paper.<\/jats:p>\n                  <\/jats:list-item>\n                <\/jats:list><\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41390-023-02707-x","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T08:02:40Z","timestamp":1687939360000},"page":"1631-1638","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Advances in neonatal cell therapies: Proceedings of the First Neonatal Cell Therapies Symposium (2022)"],"prefix":"10.1038","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9664-4182","authenticated-orcid":false,"given":"Atul","family":"Malhotra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Thebaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison C. B.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobbi","family":"Fleiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Papagianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bennet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Yawno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngaire","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belinda","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirat","family":"Chand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayla","family":"Penny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair J.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney A.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"2707_CR1","doi-asserted-by":"publisher","first-page":"1111829","DOI":"10.3389\/fped.2023.1111829","volume":"11","author":"J Xiong","year":"2023","unstructured":"Xiong, J. et al. Dose-dependent effects of human umbilical cord-derived mesenchymal stem cell treatment in hyperoxia-induced lung injury of neonatal rats. Front. Pediatr. 11, 1111829 (2023).","journal-title":"Front. Pediatr."},{"key":"2707_CR2","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1002\/ppul.26317","volume":"58","author":"J Wang","year":"2023","unstructured":"Wang, J., Zhang, A., Huang, F., Xu, J. & Zhao, M. MSC-EXO and tempol ameliorate bronchopulmonary dysplasia in newborn rats by activating HIF-1\u03b1. Pediatr. Pulmonol. 58, 1367\u20131379 (2023).","journal-title":"Pediatr. Pulmonol."},{"key":"2707_CR3","doi-asserted-by":"publisher","first-page":"556","DOI":"10.4252\/wjsc.v14.i7.556","volume":"14","author":"N Dong","year":"2022","unstructured":"Dong, N. et al. Intratracheal administration of umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced multi-organ injury via heme oxygenase-1 and JAK\/STAT pathways. World J. Stem Cells 14, 556\u2013576 (2022).","journal-title":"World J. Stem Cells"},{"key":"2707_CR4","doi-asserted-by":"publisher","first-page":"10604","DOI":"10.3390\/ijms231810604","volume":"23","author":"YE Kim","year":"2022","unstructured":"Kim, Y. E., Ahn, S. Y., Sung, D. K., Chang, Y. S. & Park, W. S. Mesenchymal stem cells and formyl peptide receptor 2 activity in hyperoxia-induced lung injury in newborn mice. Int. J. Mol. Sci. 23, 10604 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2707_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/stcltm\/szab011","volume":"11","author":"M Benny","year":"2022","unstructured":"Benny, M. et al. Comparative effects of bone marrow-derived versus umbilical cord tissue mesenchymal stem cells in an experimental model of bronchopulmonary dysplasia. Stem Cells Transl. Med. 11, 189\u2013199 (2022).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR6","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1164\/rccm.202102-0329OC","volume":"204","author":"GR Willis","year":"2021","unstructured":"Willis, G. R. et al. Extracellular vesicles protect the neonatal lung from hyperoxic injury through the epigenetic and transcriptomic reprogramming of myeloid cells. Am. J. Respir. Crit. Care Med. 204, 1418\u20131432 (2021).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2707_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/stcltm\/szac088","volume":"12","author":"MA M\u00f6bius","year":"2023","unstructured":"M\u00f6bius, M. A. et al. Prophylactic administration of mesenchymal stromal cells does not prevent arrested lung development in extremely premature-born non-human primates. Stem Cells Transl. Med. 12, 97\u2013111 (2023).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR8","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3390\/cells12050760","volume":"12","author":"L Provitera","year":"2023","unstructured":"Provitera, L. et al. Human bone marrow-derived mesenchymal stromal cells reduce the severity of experimental necrotizing enterocolitis in a concentration-dependent manner. Cells 12, 760 (2023).","journal-title":"Cells"},{"key":"2707_CR9","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1080\/01443615.2022.2158318","volume":"42","author":"B Kocabiyik","year":"2022","unstructured":"Kocabiyik, B., Gumus, E., Abas, B. I., Anik, A. & Cevik, O. Human wharton-jelly mesenchymal stromal cells reversed apoptosis and prevented multi-organ damage in a newborn model of experimental asphyxia. J. Obstet. Gynaecol. 42, 3568\u20133576 (2022).","journal-title":"J. Obstet. Gynaecol."},{"key":"2707_CR10","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.4103\/1673-5374.339002","volume":"17","author":"Y Jiao","year":"2022","unstructured":"Jiao, Y. et al. Human umbilical cord-derived mesenchymal stem cells promote repair of neonatal brain injury caused by hypoxia\/ischemia in rats. Neural Regen. Res. 17, 2518\u20132525 (2022).","journal-title":"Neural Regen. Res."},{"key":"2707_CR11","doi-asserted-by":"publisher","first-page":"152178","DOI":"10.1016\/j.imbio.2022.152178","volume":"227","author":"J Shu","year":"2022","unstructured":"Shu, J. et al. Human bone marrow mesenchymal stem cells-derived exosomes protect against nerve injury via regulating immune microenvironment in neonatal hypoxic-ischemic brain damage model. Immunobiology 227, 152178 (2022).","journal-title":"Immunobiology"},{"key":"2707_CR12","doi-asserted-by":"publisher","first-page":"11395","DOI":"10.3390\/ijms222111395","volume":"22","author":"SY Ahn","year":"2021","unstructured":"Ahn, S. Y. et al. BDNF-overexpressing engineered mesenchymal stem cells enhances their therapeutic efficacy against severe neonatal hypoxic ischemic brain injury. Int. J. Mol. Sci. 22, 11395 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2707_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/stcltm\/szad006","volume":"12","author":"E Purcell","year":"2023","unstructured":"Purcell, E. et al. Factors influencing the efficacy of umbilical cord blood-derived cell therapy for perinatal brain injury. Stem Cells Transl. Med. 12, 125\u2013139 (2023).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR14","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3390\/ijms20102449","volume":"20","author":"CA McDonald","year":"2019","unstructured":"McDonald, C. A. et al. Intranasal delivery of mesenchymal stromal cells protects against neonatal hypoxic\u2212ischemic brain injury. Int. J. Mol. Sci. 20, 2449 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"2707_CR15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s10517-022-05663-4","volume":"174","author":"MG Devyaltovskaya","year":"2022","unstructured":"Devyaltovskaya, M. G., Nikitchanko, D. Y., Potapnev, M. P., Petyovka, N. V. & Kastsiunina, V. S. The first experience of application the umbilical cord-derived human autologous mesenchymal stromal cells for the rehabilitation therapy of premature infants with extremely low body weight and hypoxic-ischemic encephalopathy. Bull. Exp. Biol. Med. 174, 142\u2013146 (2022).","journal-title":"Bull. Exp. Biol. Med."},{"key":"2707_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jpeds.2022.09.002","volume":"252","author":"AH Jobe","year":"2023","unstructured":"Jobe, A. H. Three existential challenges in optimizing the lifelong health of infants born preterm. J. Pediatr. 252, 188\u2013190 (2023).","journal-title":"J. Pediatr."},{"key":"2707_CR17","doi-asserted-by":"publisher","first-page":"e164396","DOI":"10.1001\/jamapediatrics.2016.4396","volume":"171","author":"JD Horbar","year":"2017","unstructured":"Horbar, J. D. et al. Variation in performance of neonatal intensive care units in the United States. JAMA Pediatr. 171, e164396 (2017).","journal-title":"JAMA Pediatr."},{"key":"2707_CR18","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/jp.2011.68","volume":"32","author":"PS Shah","year":"2012","unstructured":"Shah, P. S. et al. Outcomes of preterm infants <29 weeks gestation over 10-year period in Canada: a cause for concern? J. Perinatol. 32, 132\u2013138 (2012).","journal-title":"J. Perinatol."},{"key":"2707_CR19","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","volume":"5","author":"B Thebaud","year":"2019","unstructured":"Thebaud, B. et al. Bronchopulmonary dysplasia. Nat. Rev. Dis. Prim. 5, 78 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"2707_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1164\/rccm.201710-2016OC","volume":"198","author":"KN Goss","year":"2018","unstructured":"Goss, K. N. et al. Early pulmonary vascular disease in young adults born preterm. Am. J. Respir. Crit. Care Med. 198, 1549\u20131558 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2707_CR21","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1183\/09031936.00127107","volume":"32","author":"PM Wong","year":"2008","unstructured":"Wong, P. M. et al. Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur. Respir. J. 32, 321\u2013328 (2008).","journal-title":"Eur. Respir. J."},{"key":"2707_CR22","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.stem.2021.09.006","volume":"28","author":"M Krampera","year":"2021","unstructured":"Krampera, M. & Le Blanc, K. Mesenchymal stromal cells: putative microenvironmental modulators become cell therapy. Cell Stem Cell 28, 1708\u20131725 (2021).","journal-title":"Cell Stem Cell"},{"key":"2707_CR23","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1002\/sctm.17-0126","volume":"6","author":"S Augustine","year":"2017","unstructured":"Augustine, S. et al. Mesenchymal stromal cell therapy in bronchopulmonary dysplasia: systematic review and meta-analysis of preclinical studies. Stem Cells Transl. Med. 6, 2079\u20132093 (2017).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/sctm.19-0193","volume":"9","author":"S Augustine","year":"2020","unstructured":"Augustine, S. et al. Are all stem cells equal? Systematic review, evidence map, and meta-analyses of preclinical stem cell-based therapies for bronchopulmonary dysplasia. Stem Cells Transl. Med. 9, 158\u2013168 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR25","doi-asserted-by":"publisher","first-page":"F583","DOI":"10.1136\/archdischild-2017-314451","volume":"103","author":"B Thebaud","year":"2018","unstructured":"Thebaud, B. Stem cell-based therapies in neonatology: a new hope. Arch. Dis. Child. Fetal Neonatal Ed. 103, F583\u2013F588 (2018).","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"2707_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1164\/rccm.201705-0925OC","volume":"197","author":"GR Willis","year":"2018","unstructured":"Willis, G. R. et al. Mesenchymal stromal cell exosomes ameliorate experimental bronchopulmonary dysplasia and restore lung function through macrophage immunomodulation. Am. J. Respir. Crit. Care Med. 197, 104\u2013116 (2018).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2707_CR27","doi-asserted-by":"publisher","first-page":"49.e2","DOI":"10.1016\/j.jpeds.2017.02.061","volume":"185","author":"SY Ahn","year":"2017","unstructured":"Ahn, S. Y., Chang, Y. S., Kim, J. H., Sung, S. I. & Park, W. S. Two-year follow-up outcomes of premature infants enrolled in the phase I trial of mesenchymal stem cells transplantation for bronchopulmonary dysplasia. J. Pediatr. 185, 49.e2\u201354.e2 (2017).","journal-title":"J. Pediatr."},{"key":"2707_CR28","doi-asserted-by":"publisher","first-page":"966.e6","DOI":"10.1016\/j.jpeds.2013.12.011","volume":"164","author":"YS Chang","year":"2014","unstructured":"Chang, Y. S. et al. Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J. Pediatr. 164, 966.e6\u2013972.e6 (2014).","journal-title":"J. Pediatr."},{"key":"2707_CR29","doi-asserted-by":"publisher","first-page":"209.e2","DOI":"10.1016\/j.jpeds.2019.02.029","volume":"210","author":"SB Powell","year":"2019","unstructured":"Powell, S. B. & Silvestri, J. M. Safety of intratracheal administration of human umbilical cord blood derived mesenchymal stromal cells in extremely low birth weight preterm infants. J. Pediatr. 210, 209.e2\u2013213.e2 (2019).","journal-title":"J. Pediatr."},{"key":"2707_CR30","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1002\/sctm.20-0330","volume":"10","author":"SY Ahn","year":"2021","unstructured":"Ahn, S. Y. et al. Stem cells for bronchopulmonary dysplasia in preterm infants: a randomized controlled phase II trial. Stem Cells Transl. Med. 10, 1129\u20131137 (2021).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR31","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/crj.13540","volume":"16","author":"E Tang","year":"2022","unstructured":"Tang, E. et al. Headway and the remaining hurdles of mesenchymal stem cells therapy for bronchopulmonary dysplasia. Clin. Respir. J. 16, 629\u2013645 (2022).","journal-title":"Clin. Respir. J."},{"key":"2707_CR32","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2018.05.004","volume":"22","author":"J Galipeau","year":"2018","unstructured":"Galipeau, J. & Sensebe, L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell 22, 824\u2013833 (2018).","journal-title":"Cell Stem Cell"},{"key":"2707_CR33","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1513\/AnnalsATS.201811-843PS","volume":"16","author":"S Purdon","year":"2019","unstructured":"Purdon, S. & Glassberg, M. K. Multipotent mesenchymal stromal cells and lung disease: not ready for prime time. Ann. Am. Thorac. Soc. 16, 669\u2013671 (2019).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"2707_CR34","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/d41586-018-06756-9","volume":"561","author":"D Sipp","year":"2018","unstructured":"Sipp, D., Robey, P. G. & Turner, L. Clear up this stem-cell mess. Nature 561, 455\u2013457 (2018).","journal-title":"Nature"},{"key":"2707_CR35","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/stcltm\/szab009","volume":"11","author":"L Renesme","year":"2022","unstructured":"Renesme, L. et al. Definition and characteristics of mesenchymal stromal cells in preclinical and clinical studies: a scoping review. Stem Cells Transl. Med. 11, 44\u201354 (2022).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR36","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1016\/j.stem.2021.09.001","volume":"28","author":"H Soliman","year":"2021","unstructured":"Soliman, H. et al. Multipotent stromal cells: one name, multiple identities. Cell Stem Cell 28, 1690\u20131707 (2021).","journal-title":"Cell Stem Cell"},{"key":"2707_CR37","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.3390\/cells11071176","volume":"11","author":"F Lesage","year":"2022","unstructured":"Lesage, F. & Th\u00e9baud, B. Mesenchymal stromal cell-derived extracellular vesicles for neonatal lung disease: tiny particles, major promise, rigorous requirements for clinical translation. Cells 11, 1176 (2022).","journal-title":"Cells"},{"key":"2707_CR38","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry, C. et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 7, 1535750 (2018).","journal-title":"J. Extracell. Vesicles"},{"key":"2707_CR39","unstructured":"Clinical Trial: Mesenchymal Stromal Cells for Infants With Congenital Heart Disease (MedCaP). US Fed News Service, Including US State News. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04236479 (2020)."},{"key":"2707_CR40","doi-asserted-by":"publisher","first-page":"S192","DOI":"10.1016\/j.jcyt.2020.04.052","volume":"22","author":"CM Cotten","year":"2020","unstructured":"Cotten, C. M., Fisher, K., Kurtzberg, J. & Simmons, R. Phase I trial of allogeneic umbilical cord tissue-derived mesenchymal stromal cells in neonates with hypoxic-ischemic encephalopathy. Cytotherapy 22, S192 (2020).","journal-title":"Cytotherapy"},{"key":"2707_CR41","doi-asserted-by":"publisher","first-page":"e057073","DOI":"10.1136\/bmjopen-2021-057073","volume":"12","author":"N Matsuyama","year":"2022","unstructured":"Matsuyama, N. et al. Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial. BMJ Open 12, e057073 (2022).","journal-title":"BMJ Open"},{"key":"2707_CR42","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3345\/kjp.2014.57.6.251","volume":"57","author":"SY Ahn","year":"2014","unstructured":"Ahn, S. Y., Chang, Y. S. & Park, W. S. Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage. Korean J. Pediatr. 57, 251\u2013256 (2014).","journal-title":"Korean J. Pediatr."},{"key":"2707_CR43","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S1474-4422(22)00117-X","volume":"21","author":"LM Baak","year":"2022","unstructured":"Baak, L. M. et al. Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study. Lancet Neurol. 21, 528\u2013536 (2022).","journal-title":"Lancet Neurol."},{"key":"2707_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.expneurol.2014.06.009","volume":"261","author":"V Donega","year":"2014","unstructured":"Donega, V. et al. Intranasally administered mesenchymal stem cells promote a regenerative niche for repair of neonatal ischemic brain injury. Exp. Neurol. 261, 53\u201364 (2014).","journal-title":"Exp. Neurol."},{"key":"2707_CR45","doi-asserted-by":"publisher","first-page":"7862","DOI":"10.3390\/ijms22157862","volume":"22","author":"HK Basham","year":"2021","unstructured":"Basham, H. K., Aghoghovwia, B. E., Papaioannou, P., Seo, S. & Oorschot, D. E. Delayed double treatment with adult-sourced adipose-derived mesenchymal stem cells increases striatal medium-spiny neuronal number, decreases striatal microglial number, and has no subventricular proliferative effect, after acute neonatal hypoxia-ischemia in male rats. Int. J. Mol. Sci. 22, 7862 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"2707_CR46","doi-asserted-by":"publisher","first-page":"754","DOI":"10.5966\/sctm.2015-0197","volume":"5","author":"RMG Ophelders Daan","year":"2016","unstructured":"Ophelders Daan, R. M. G. et al. Mesenchymal stromal cell\u2010derived extracellular vesicles protect the fetal brain after hypoxia\u2010ischemia. Stem Cells Transl. Med. 5, 754\u2013763 (2016).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR47","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/pr.2017.251","volume":"83","author":"PF Maillacheruvu","year":"2018","unstructured":"Maillacheruvu, P. F., Engel, L. M., Crum, I. T., Agrawal, D. K. & Peeples, E. S. From cord to caudate: characterizing umbilical cord blood stem cells and their paracrine interactions with the injured brain. Pediatr. Res. 83, 205\u2013213 (2018).","journal-title":"Pediatr. Res."},{"key":"2707_CR48","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1046\/j.1365-2141.1997.2583074.x","volume":"98","author":"M Nieda","year":"1997","unstructured":"Nieda, M. et al. Endothelial cell precursors are normal components of human umbilical cord blood. Br. J. Haematol. 98, 775\u2013777 (1997).","journal-title":"Br. J. Haematol."},{"key":"2707_CR49","doi-asserted-by":"publisher","first-page":"1277.e14","DOI":"10.1016\/j.cell.2018.06.045","volume":"174","author":"A Olin","year":"2018","unstructured":"Olin, A. et al. Stereotypic immune system development in newborn children. Cell 174, 1277.e14\u20131292.e14 (2018).","journal-title":"Cell"},{"key":"2707_CR50","doi-asserted-by":"publisher","first-page":"973.e1","DOI":"10.1016\/j.jpeds.2013.11.036","volume":"164","author":"CMMD Cotten","year":"2014","unstructured":"Cotten, C. M. M. D. et al. Feasibility of autologous cord blood cells for infants with hypoxic-ischemic encephalopathy. J. Pediatr. 164, 973.e1\u2013979.e1 (2014).","journal-title":"J. Pediatr."},{"key":"2707_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/sctm.19-0106","volume":"9","author":"Z Ren","year":"2020","unstructured":"Ren, Z. et al. Autologous cord blood cell infusion in preterm neonates safely reduces respiratory support duration and potentially preterm complications. Stem Cells Transl. Med. 9, 169\u2013176 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR52","doi-asserted-by":"publisher","first-page":"585.e4","DOI":"10.1016\/j.athoracsur.2009.10.035","volume":"89","author":"BMP Davies","year":"2010","unstructured":"Davies, B. M. P. et al. Human cord blood stem cells enhance neonatal right ventricular function in an ovine model of right ventricular training. Ann. Thorac. Surg. 89, 585.e4\u2013593.e4 (2010).","journal-title":"Ann. Thorac. Surg."},{"key":"2707_CR53","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.athoracsur.2015.04.130","volume":"100","author":"CPMD Brizard","year":"2015","unstructured":"Brizard, C. P. M. D. et al. Safety of intracoronary human cord blood stem cells in a lamb model of infant cardiopulmonary bypass. Ann. Thorac. Surg. 100, 1021\u20131029 (2015).","journal-title":"Ann. Thorac. Surg."},{"key":"2707_CR54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13287-015-0044-y","volume":"6","author":"S Oommen","year":"2015","unstructured":"Oommen, S. et al. Human umbilical cord blood-derived mononuclear cells improve murine ventricular function upon intramyocardial delivery in right ventricular chronic pressure overload. Stem Cell Res. Ther. 6, 50 (2015).","journal-title":"Stem Cell Res. Ther."},{"key":"2707_CR55","doi-asserted-by":"publisher","first-page":"4351","DOI":"10.3390\/ijms24054351","volume":"24","author":"T Nguyen","year":"2023","unstructured":"Nguyen, T. et al. Umbilical cord blood-derived cell therapy for perinatal brain injury: a systematic review & meta-analysis of preclinical studies. Int. J. Mol. Sci. 24, 4351 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2707_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95035-1","volume":"11","author":"TR Penny","year":"2021","unstructured":"Penny, T. R. et al. Umbilical cord blood therapy modulates neonatal hypoxic ischemic brain injury in both females and males. Sci. Rep. 11, 15788 (2021).","journal-title":"Sci. Rep."},{"key":"2707_CR57","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1002\/sctm.12808","volume":"9","author":"T Penny","year":"2020","unstructured":"Penny, T. et al. Multiple doses of umbilical cord blood cells improve long\u2010term perinatal brain injury. Stem Cells Transl. Med. 9, S3 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR58","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/stcltm\/szab024","volume":"11","author":"L Zhou","year":"2022","unstructured":"Zhou, L. et al. Umbilical cord blood and cord tissue-derived cell therapies for neonatal morbidities: current status and future challenges. Stem Cells Transl. Med. 11, 135\u2013145 (2022).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR59","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jcyt.2023.01.001","volume":"25","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. Feasibility of cord blood collection for autologous cell therapy applications in extremely preterm infants. Cytotherapy 25, 458\u2013462 (2023).","journal-title":"Cytotherapy"},{"key":"2707_CR60","doi-asserted-by":"publisher","first-page":"e036065","DOI":"10.1136\/bmjopen-2019-036065","volume":"10","author":"A Malhotra","year":"2020","unstructured":"Malhotra, A., Novak, I., Miller, S. L. & Jenkin, G. Autologous transplantation of umbilical cord blood-derived cells in extreme preterm infants: protocol for a safety and feasibility study. BMJ Open 10, e036065 (2020).","journal-title":"BMJ Open"},{"key":"2707_CR61","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1080\/14728222.2021.1978069","volume":"25","author":"AT Bejjani","year":"2021","unstructured":"Bejjani, A. T., Wary, N. & Gu, M. Hypoplastic left heart syndrome (HLHS): molecular pathogenesis and emerging drug targets for cardiac repair and regeneration. Expert Opin. Ther. Targets 25, 621\u2013632 (2021).","journal-title":"Expert Opin. Ther. Targets"},{"key":"2707_CR62","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ahj.2022.09.005","volume":"254","author":"CS Goldberg","year":"2022","unstructured":"Goldberg, C. S. et al. The pediatric heart network\u2019s study on long-term outcomes of children with HLHS and the impact of Norwood Shunt type in the single ventricle reconstruction trial cohort (SVRIII): design and adaptations. Am. Heart J. 254, 216\u2013227 (2022).","journal-title":"Am. Heart J."},{"key":"2707_CR63","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.jtcvs.2019.06.001","volume":"158","author":"HM Burkhart","year":"2019","unstructured":"Burkhart, H. M. et al. Autologous stem cell therapy for hypoplastic left heart syndrome: safety and feasibility of intraoperative intramyocardial injections. J. Thorac. Cardiovasc. Surg. 158, 1614\u20131623 (2019).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"2707_CR64","doi-asserted-by":"publisher","first-page":"e0173572","DOI":"10.1371\/journal.pone.0173572","volume":"12","author":"JM Melville","year":"2017","unstructured":"Melville, J. M. et al. Human amnion epithelial cells modulate the inflammatory response to ventilation in preterm lambs. PLoS ONE 12, e0173572 (2017).","journal-title":"PLoS ONE"},{"key":"2707_CR65","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.jcyt.2013.03.004","volume":"15","author":"P Vosdoganes","year":"2013","unstructured":"Vosdoganes, P. et al. Human amnion epithelial cells modulate hyperoxia-induced neonatal lung injury in mice. Cytotherapy 15, 1021\u20131029 (2013).","journal-title":"Cytotherapy"},{"key":"2707_CR66","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1002\/sctm.18-0079","volume":"7","author":"R Lim","year":"2018","unstructured":"Lim, R. et al. First-in-human administration of allogeneic amnion cells in premature infants with bronchopulmonary dysplasia: a safety study. Stem Cells Transl. Med. 7, 628\u2013635 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR67","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/sctm.19-0251","volume":"9","author":"A Malhotra","year":"2020","unstructured":"Malhotra, A., Lim, R., Mockler, J. C. & Wallace, E. M. Two-year outcomes of infants enrolled in the first-in-human study of amnion cells for bronchopulmonary dysplasia. Stem Cells Transl. Med. 9, 289\u2013294 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR68","doi-asserted-by":"publisher","first-page":"101322","DOI":"10.1016\/j.siny.2021.101322","volume":"27","author":"A Damianos","year":"2022","unstructured":"Damianos, A., Xu, K., Kalin, G. T. & Kalinichenko, V. V. Placental tissue stem cells and their role in neonatal diseases. Semin. Fetal Neonatal Med. 27, 101322 (2022).","journal-title":"Semin. Fetal Neonatal Med."},{"key":"2707_CR69","doi-asserted-by":"publisher","first-page":"5571","DOI":"10.1113\/JP274949","volume":"596","author":"SK Dhillon","year":"2018","unstructured":"Dhillon, S. K. et al. The fetus at the tipping point: modifying the outcome of fetal asphyxia. J. Physiol. 596, 5571\u20135592 (2018).","journal-title":"J. Physiol."},{"key":"2707_CR70","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.4103\/1673-5374.327339","volume":"17","author":"J Davidson","year":"2022","unstructured":"Davidson, J., Dhillon, S. & Bennet, L. Preterm neonatal brain injury: are human amnion epithelial stem cells a pan-treatment for neuroprotection and neurorepair? Neural Regen. Res. 17, 1261\u20131262 (2022).","journal-title":"Neural Regen. Res."},{"key":"2707_CR71","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/sctm.20-0314","volume":"10","author":"JO Davidson","year":"2021","unstructured":"Davidson, J. O. et al. Window of opportunity for human amnion epithelial stem cells to attenuate astrogliosis after umbilical cord occlusion in preterm fetal sheep. Stem Cells Transl. Med. 10, 427\u2013440 (2021).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR72","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0271678X17729954","volume":"39","author":"LG van den Heuij","year":"2019","unstructured":"van den Heuij, L. G. et al. Delayed intranasal infusion of human amnion epithelial cells improves white matter maturation after asphyxia in preterm fetal sheep. J. Cereb. Blood Flow Metab. 39, 223\u2013239 (2019).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2707_CR73","doi-asserted-by":"publisher","first-page":"8393","DOI":"10.3390\/ijms23158393","volume":"23","author":"JO Davidson","year":"2022","unstructured":"Davidson, J. O. et al. Lack of neuroprotection with a single intravenous infusion of human amnion epithelial cells after severe hypoxia\u2013ischemia in near-term fetal sheep. Int. J. Mol. Sci. 23, 8393 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"2707_CR74","doi-asserted-by":"publisher","first-page":"9603","DOI":"10.1523\/JNEUROSCI.1835-10.2010","volume":"30","author":"CTJ van Velthoven","year":"2010","unstructured":"van Velthoven, C. T. J., Kavelaars, A., van Bel, F. & Heijnen, C. J. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J. Neurosci. 30, 9603\u20139611 (2010).","journal-title":"J. Neurosci."},{"key":"2707_CR75","doi-asserted-by":"publisher","first-page":"e0253456","DOI":"10.1371\/journal.pone.0253456","volume":"16","author":"CP Paris","year":"2021","unstructured":"Paris, C. P. et al. The effect of human amnion epithelial cells on lung development and inflammation in preterm lambs exposed to antenatal inflammation. PLoS ONE 16, e0253456 (2021).","journal-title":"PLoS ONE"},{"key":"2707_CR76","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13287-017-0689-9","volume":"8","author":"D Zhu","year":"2017","unstructured":"Zhu, D. et al. Human amnion cells reverse acute and chronic pulmonary damage in experimental neonatal lung injury. Stem Cell Res. Ther. 8, 257 (2017).","journal-title":"Stem Cell Res. Ther."},{"key":"2707_CR77","doi-asserted-by":"publisher","first-page":"e026265","DOI":"10.1136\/bmjopen-2018-026265","volume":"9","author":"EK Baker","year":"2019","unstructured":"Baker, E. K. et al. Human amnion cells for the prevention of bronchopulmonary dysplasia: a protocol for a phase I dose escalation study. BMJ Open 9, e026265 (2019).","journal-title":"BMJ Open"},{"key":"2707_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41536-021-00185-5","volume":"6","author":"KK Chand","year":"2021","unstructured":"Chand, K. K. et al. Combination of human endothelial colony-forming cells and mesenchymal stromal cells exert neuroprotective effects in the growth-restricted newborn. npj Regener. Med. 6, 75 (2021).","journal-title":"npj Regener. Med."},{"key":"2707_CR79","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/sctm.17-0185","volume":"7","author":"JL Tan","year":"2018","unstructured":"Tan, J. L. et al. Amnion epithelial cell\u2010derived exosomes restrict lung injury and enhance endogenous lung repair. Stem Cells Transl. Med. 7, 180\u2013196 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR80","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles 4, 27066 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"2707_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2018.01.005","volume":"196","author":"H Jing","year":"2018","unstructured":"Jing, H., He, X. & Zheng, J. Exosomes and regenerative medicine: state of the art and perspectives. Transl. Res. 196, 1\u201316 (2018).","journal-title":"Transl. Res."},{"key":"2707_CR82","doi-asserted-by":"publisher","first-page":"703","DOI":"10.12688\/f1000research.25338.1","volume":"9","author":"M Sahni","year":"2020","unstructured":"Sahni, M. & Bhandari, V. Recent advances in understanding and management of bronchopulmonary dysplasia [version 1 peer review: 2 approved]. F1000 Res. 9, 703 (2020).","journal-title":"F1000 Res."},{"key":"2707_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3389\/fphys.2019.00015","volume":"10","author":"M Finch-Edmondson","year":"2019","unstructured":"Finch-Edmondson, M., Morgan, C., Hunt, R. W. & Novak, I. Emergent prophylactic, reparative and restorative brain interventions for infants born preterm with cerebral palsy. Front. Physiol. 10, 15 (2019).","journal-title":"Front. Physiol."},{"key":"2707_CR84","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/sctm.17-0219","volume":"7","author":"A So Yoon","year":"2018","unstructured":"So Yoon, A., Chang, Y. S., Se In, S. & Park, W. S. Mesenchymal stem cells for severe intraventricular hemorrhage in preterm infants: phase I dose\u2010escalation clinical trial. Stem Cells Transl. Med. 7, 847\u2013856 (2018).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR85","doi-asserted-by":"publisher","first-page":"243.e1","DOI":"10.1016\/j.jpeds.2019.09.060","volume":"219","author":"JM Davis","year":"2020","unstructured":"Davis, J. M. et al. Standardizing safety assessment and reporting for neonatal clinical trials. J. Pediatr. 219, 243.e1\u2013249.e1 (2020).","journal-title":"J. Pediatr."},{"key":"2707_CR86","doi-asserted-by":"publisher","first-page":"41.e7","DOI":"10.1016\/j.jpeds.2019.03.005","volume":"210","author":"M Guillot","year":"2019","unstructured":"Guillot, M. et al. So you want to give stem cells to babies? neonatologists and parents\u2019 views to optimize clinical trials. J. Pediatr. 210, 41.e7\u201347.e1 (2019).","journal-title":"J. Pediatr."},{"key":"2707_CR87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11910-019-0916-0","volume":"19","author":"G Wassink","year":"2019","unstructured":"Wassink, G. et al. Therapeutic hypothermia in neonatal hypoxic-ischemic encephalopathy. Curr. Neurol. Neurosci. Rep. 19, 2\u201310 (2019).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"2707_CR88","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1203\/00006450-199804001-01037","volume":"43","author":"TR Gunn","year":"1998","unstructured":"Gunn, T. R., Gunn, A. J. & Gluckman, P. D. Selective head cooling in newborn infants following perinatal asphyxia: a safety study. Pediatr. Res. 43, 175 (1998).","journal-title":"Pediatr. Res."},{"key":"2707_CR89","first-page":"CD003311","volume":"2013","author":"SE Jacobs","year":"2013","unstructured":"Jacobs, S. E. et al. Cooling for newborns with hypoxic ischaemic encephalopathy. Cochrane Database Syst. Rev. 2013, CD003311 (2013).","journal-title":"Cochrane Database Syst. Rev."},{"key":"2707_CR90","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1542\/peds.107.3.480","volume":"107","author":"MR Battin","year":"2001","unstructured":"Battin, M. R., Dezoete, J. A., Gunn, T. R., Gluckman, P. D. & Gunn, A. J. Neurodevelopmental outcome of infants treated with head cooling and mild hypothermia after perinatal asphyxia. Pediatrics 107, 480\u2013484 (2001).","journal-title":"Pediatrics"},{"key":"2707_CR91","doi-asserted-by":"publisher","first-page":"5641","DOI":"10.1113\/JP274928","volume":"596","author":"G Wassink","year":"2018","unstructured":"Wassink, G. et al. A working model for hypothermic neuroprotection. J. Physiol. 596, 5641\u20135654 (2018).","journal-title":"J. Physiol."},{"key":"2707_CR92","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1172\/JCI119153","volume":"99","author":"AJ Gunn","year":"1997","unstructured":"Gunn, A. J., Gunn, T. R., de Haan, H. H., Williams, C. E. & Gluckman, P. D. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J. Clin. Investig. 99, 248\u2013256 (1997).","journal-title":"J. Clin. Investig."},{"key":"2707_CR93","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1177\/0271678X17707671","volume":"38","author":"JO Davidson","year":"2018","unstructured":"Davidson, J. O. et al. How long is sufficient for optimal neuroprotection with cerebral cooling after ischemia in fetal sheep? J. Cereb. Blood Flow Metab. 38, 1047\u20131059 (2018).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"2707_CR94","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ana.22387","volume":"70","author":"S Faulkner","year":"2011","unstructured":"Faulkner, S. et al. Xenon augmented hypothermia reduces early lactate\/N-acetylaspartate and cell death in perinatal asphyxia. Ann. Neurol. 70, 133\u2013150 (2011).","journal-title":"Ann. Neurol."},{"key":"2707_CR95","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S1474-4422(15)00386-5","volume":"15","author":"AJ Gunn","year":"2016","unstructured":"Gunn, A. J. & Bennet, L. Timing still key to treating hypoxic ischaemic brain injury. Lancet Neurol. 15, 126\u2013127 (2016).","journal-title":"Lancet Neurol."},{"key":"2707_CR96","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1113\/JP279131","volume":"598","author":"G Wassink","year":"2020","unstructured":"Wassink, G. et al. Non\u2010additive effects of adjunct erythropoietin therapy with therapeutic hypothermia after global cerebral ischaemia in near\u2010term fetal sheep. J. Physiol. 598, 999\u20131015 (2020).","journal-title":"J. Physiol."},{"key":"2707_CR97","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1113\/JP281269","volume":"599","author":"SK Dhillon","year":"2021","unstructured":"Dhillon, S. K. et al. Adverse neural effects of delayed, intermittent treatment with rEPO after asphyxia in preterm fetal sheep. J. Physiol. 599, 3593\u20133609 (2021).","journal-title":"J. Physiol."},{"key":"2707_CR98","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa2119660","volume":"387","author":"YW Wu","year":"2022","unstructured":"Wu, Y. W. et al. Trial of erythropoietin for hypoxic\u2013ischemic encephalopathy in newborns. N. Engl. J. Med. 387, 148\u201359 (2022).","journal-title":"N. Engl. J. Med."},{"key":"2707_CR99","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S1474-4422(15)00347-6","volume":"15","author":"DP Azzopardi","year":"2016","unstructured":"Azzopardi, D. P. et al. Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial. Lancet Neurol. 15, 145\u2013153 (2016).","journal-title":"Lancet Neurol."},{"key":"2707_CR100","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/sctm.20-0281","volume":"10","author":"EK Baker","year":"2021","unstructured":"Baker, E. K. et al. A protocol for cell therapy infusion in neonates. Stem Cells Transl. Med. 10, 773\u2013780 (2021).","journal-title":"Stem Cells Transl. Med."},{"key":"2707_CR101","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbi.2018.02.006","volume":"70","author":"J Herz","year":"2018","unstructured":"Herz, J. et al. Interaction between hypothermia and delayed mesenchymal stem cell therapy in neonatal hypoxic-ischemic brain injury. Brain Behav. Immun. 70, 118\u2013130 (2018).","journal-title":"Brain Behav. Immun."},{"key":"2707_CR102","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/jpc.15191","volume":"57","author":"AR King","year":"2021","unstructured":"King, A. R. et al. Early detection of cerebral palsy in high-risk infants: translation of evidence into practice in an Australian hospital. J. Paediatr. Child Health 57, 246\u2013250 (2021).","journal-title":"J. Paediatr. Child Health"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02707-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02707-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T13:05:40Z","timestamp":1699016740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-023-02707-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":102,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["2707"],"URL":"https:\/\/doi.org\/10.1038\/s41390-023-02707-x","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}